Paul P. Dobesh, Pharm.D., FCCP, BCPS
Paul P. Dobesh, Pharm.D., FCCP, BCPS

Professor

Department of Pharmacy Practice
College of Pharmacy
University of Nebraska Medical Center
986145 Nebraska Medical Center
Omaha, NE 68198-6145
Phone: (402) 559-3982
Cell: (402) 214-5498
Fax: (402) 559-5673
Email
 
Teaching Activities:
Dr. Dobesh is the Cardiology Section Coordinator in the Pharmacotherapy I course.  He also co-coordinates the Pharmaceutical Care II course and teaches the physical assessment portion of the course.  Dr. Dobesh serves as the primary preceptor for the Cardiology Clerkship, as well as for an elective clerkship in the nation of Belize.

Research Activities/Interests:
Dr. Dobesh is responsible for teaching pharmacy and medical students as well as pharmacy and medical residents and lectures in the area of ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics. Dr. Dobesh has conducted research on antiplatelet and antithrombotic therapy, focusing on real-world utilization and health-economics. He has also published book chapters and several manuscripts in this area.

Recent Publications:

  1. Tomaselli GT, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messe SR, Pollack CV, Rodriguez F, Sarode R, Siegal D, Wiggins BS. 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants.  J Am Coll Cardiol 2017;70:3042-3067.
  2. Fanikos J, Burnett AE, Mahan CE, Dobesh PP.  Renal function and direct oral anticoagulant treatment for venous thromboembolism. Am J Med 2017;130:1137-1143.
  3. Dobesh PP, Patel M. The PARTHENON clinical development program: the role of ticagrelor in patients with atherothrombotic disease. Cardiovasc Drugs Ther 2017;31:433-444.
  4. Fanikos J, Burnett AE, Mahan CE, Dobesh PP.  Renal function considerations for stroke prevention in atrial fibrillation. Am J Med 2017;130:1015-1023.
  5. Dobesh PP, Fanikos J. Reducing the risk of stroke in patients with nonvalvular atrial fibrillation with direct oral anticoagulants: is one of these not like the others?  J Atr Fibrillation 2016;9:66-74.
  6. Flaker GC, Theriot P, Binder LG, Dobesh PP, Cukler A, Doherty JU.  Management of periprocedural anticoagulation: a survey of contemporary practice. J Am Coll Cardiol 2016;68:217-226.
  7. Finks SW, Trujillo TC, Dobesh PP.  Management of venous thromboembolism: recent advances in oral anticoagulation therapy. Ann Pharmacother 2016;50:486-501.
  8. Dobesh PP, Varnado S, Doyle M.  Antiplatelet agents in cardiology: a report on aspirin, clopidogrel, prasugrel, and ticagrelor.  Curr Pharm Des 2016;22:1918-1932.
  9. Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A, Wittkowsky AK. Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.  J Thromb Thrombolysis 2016;41:165-186.
  10. Oliphant CS, Trevarrow BJ, Dobesh PP. Clopidogrel response variability: review of the literature and practical considerations.  J Pharm Pract 2016;29:26-34.